Recombinant Human CCL19 Protein，His

CCL19, also known as chemokine (C-C motif) ligand 19, is a crucial member of the chemokine family that plays a significant role in immune system regulation, particularly in lymphocyte migration and tissue homing. It primarily acts by binding to its receptor, CCR7, which is essential for the trafficking of T cells and dendritic cells to lymphoid organs and inflammatory sites. Due to its pivotal role in immune responses, CCL19 has garnered attention in various fields, including immunology, oncology, and infectious diseases. In cancer research, manipulating CCL19 signaling pathways is being explored as a strategy for enhancing anti-tumor immunity and developing novel immunotherapies. Moreover, the recombinant production of CCL19 protein has facilitated its study in vitro and in vivo, allowing researchers to better understand its biological functions, receptor interactions, and potential therapeutic applications. By examining the effects of CCL19 on immune cells, scientists aim to elucidate its mechanisms of action, paving the way for innovative treatments for conditions such as cancer, autoimmunity, and chronic inflammation. The ongoing exploration of CCL19 and its recombinant protein forms continues to unveil its complexities, contributing significantly to our understanding of the immune landscape and presenting new avenues for therapeutic interventions.